Repurposing the anti-hypertensive agent Telmisartan into an anti-diabetic agent:  Telmisartan (brand name: Micardis), an antihypertensive agent, increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of  its target gene Lin28, 8/January/2018, 10.29 pm